EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Human papillomavirus type 16 E6 promotes cervical cancer proliferation by upregulating transketolase enzymatic activity through the activation of protein kinase B

Shiming Hao, Qingfei Meng, Huihui Sun, Xiangzhe Yang, Bin Liu, Yanghe Zhang, Honglan Zhou, Zhixiang Xu, Yishu Wang

Molecular Carcinogenesis · 2024-02 · 63 (2) · 339-355

DOI: 10.1002/mc.23656 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 21.11.2023. Verfasst von Shiming Hao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Pathobiology, Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin Province, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Oncogene Proteins, Viral. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, International Cooperation project of the Department of Science and Technology of Jilin Province, Health Commission of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over 99% of precancerous cervical lesions are associated with human papillomavirus (HPV) infection, with HPV types 16 and 18 (especially type 16) found in over 70% of cervical cancer cases globally. E6, a critical HPV gene, triggers malignant proliferation by degrading p53; however, this mechanism alone cannot fully explain the oncogenic effects of HPV16 E6. Therefore, we aimed to investigate new targets of HPV oncogenic mechanisms. Our results revealed significant changes in nonoxidative pentose phosphate pathway (PPP) metabolites in HPV16‐positive cells. However, the role of nonoxidative PPP in HPV‐associated cell transformation and tumor development remained unexplored. In this study, we investigated the impact and mechanisms of HPV16 E6 on cervical cancer proliferation using the HPV‐negative cervical cancer cell line (C33A). HPV16 E6 was found to promote cervical cancer cell proliferation both in vitro and in vivo, activating the nonoxidative PPP. Transketolase (TKT), a key enzyme in the nonoxidative PPP, is highly expressed in cervical cancer tissues and associated with poor prognosis. HPV16 E6 promotes cervical cancer cell proliferation by upregulating TKT activity through the activation of AKT. In addition, oxythiamine (OT), a TKT inhibitor, hindered tumor growth, with enhanced effects when combined with cisplatin (DDP). In conclusion, HPV16 E6 promotes cervical cancer proliferation by upregulating TKT activity through the activation of AKT. OT demonstrates the potential to inhibit HPV16‐positive cervical cancer growth, and when combined with DDP, could further enhance the tumor‐suppressive effect of DDP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus InfectionsOncogene Proteins, ViralFemaleHumansProto-Oncogene Proteins c-aktHuman papillomavirus 16TransketolaseCell ProliferationCell Line, Tumor

Stichwörter der Autor:innen

aerobic glycolysispentose phosphate pathwaytumor therapy

Substanzen

Proto-Oncogene Proteins c-aktTransketolaseOncogene Proteins, Viral

Autor:innen und Institutionen

  • Key Laboratory of Pathobiology, Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin Province, China.
  • Department of Urology, The First Hospital of Jilin University, Changchun, China.
  • Department of Medicine, School of Life Sciences, Henan University, Kaifeng, Henan Province, China.

Förderung

  • National Natural Science Foundation of China
  • International Cooperation project of the Department of Science and Technology of Jilin Province
  • Health Commission of Jilin Province

Zitieren

APA

Hao, S., Meng, Q., Sun, H., Yang, X., Liu, B., Zhang, Y., Zhou, H., Xu, Z., & Wang, Y. (2024). Human papillomavirus type 16 E6 promotes cervical cancer proliferation by upregulating transketolase enzymatic activity through the activation of protein kinase B. Molecular Carcinogenesis, 63(2), 339-355. https://doi.org/10.1002/mc.23656

Vancouver

Hao S, Meng Q, Sun H, Yang X, Liu B, Zhang Y, et al. Human papillomavirus type 16 E6 promotes cervical cancer proliferation by upregulating transketolase enzymatic activity through the activation of protein kinase B. Molecular Carcinogenesis. 2024;63(2):339-355. doi:10.1002/mc.23656

BibTeX
@article{Hao2024,
  author = {Hao, Shiming and Meng, Qingfei and Sun, Huihui and Yang, Xiangzhe and Liu, Bin and Zhang, Yanghe and Zhou, Honglan and Xu, Zhixiang and Wang, Yishu},
  title = {Human papillomavirus type 16 E6 promotes cervical cancer proliferation by upregulating transketolase enzymatic activity through the activation of protein kinase B},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  volume = {63},
  number = {2},
  pages = {339--355},
  doi = {10.1002/mc.23656}
}
Kostenlos starten →